Double maintains 2 strategies that include INN - Summit Hotel Properties, Inc.
Current Value
$5.401 Year Return
Current Value
$5.401 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DRH | 87.01% | $1.65B | -1.11% | 5.24% |
| RLJ | 86.14% | $1.14B | -19.53% | 7.89% |
| XHR | 85.88% | $1.30B | -5.25% | 3.90% |
| PEB | 83.98% | $1.25B | -19.37% | 0.38% |
| PK | 83.88% | $2.16B | -23.91% | 9.20% |
| APLE | 83.06% | $2.88B | -14.57% | 8.32% |
| SHO | 82.32% | $1.77B | -11.51% | 4.01% |
| HST | 81.27% | $11.22B | -8.02% | 5.52% |
| RHP | 79.09% | $6.47B | +4.63% | 4.37% |
| TNL | 74.63% | $3.71B | +28.78% | 3.76% |
| CLDT | 74.50% | $355.63M | -13.57% | 4.36% |
| AVNT | 71.66% | $3.15B | -19.18% | 3.10% |
| H | 70.78% | $13.88B | -2.71% | 0.41% |
| NDSN | 70.03% | $12.59B | -2.13% | 1.39% |
| MAR | 69.95% | $76.01B | +15.55% | 0.92% |
| TROW | 69.88% | $22.02B | -13.66% | 5.02% |
| HGV | 69.84% | $4.08B | +13.50% | 0.00% |
| HBAN | 69.68% | $25.35B | +33.44% | 3.53% |
| RF | 69.52% | $22.07B | +23.43% | 4.04% |
| PNC | 69.34% | $77.42B | +24.03% | 3.26% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IVOV | 78.67% | $928.25M | 0.1% |
| MDYV | 78.58% | $2.38B | 0.15% |
| IJJ | 78.42% | $7.68B | 0.18% |
| AVLV | 78.24% | $7.62B | 0.15% |
| RWJ | 78.06% | $1.52B | 0.39% |
| SMOT | 77.96% | $387.12M | 0.49% |
| VBR | 77.84% | $29.39B | 0.07% |
| FNDA | 77.62% | $8.30B | 0.25% |
| DON | 77.61% | $3.67B | 0.38% |
| JVAL | 77.53% | $517.37M | 0.12% |
| IVOO | 77.33% | $2.65B | 0.07% |
| SPMD | 77.28% | $13.18B | 0.03% |
| IJS | 77.26% | $6.06B | 0.18% |
| SCHM | 77.20% | $11.57B | 0.04% |
| IJH | 77.19% | $94.92B | 0.05% |
| MDY | 77.12% | $22.71B | 0.24% |
| JMEE | 77.11% | $1.84B | 0.24% |
| EZM | 77.00% | $765.44M | 0.38% |
| PY | 76.98% | $224.28M | 0.15% |
| SYLD | 76.90% | $934.26M | 0.59% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -66.18% | $99.63M | 0.59% |
| VIXY | -56.45% | $164.54M | 0.85% |
| BTAL | -48.34% | $296.22M | 1.43% |
| IVOL | -39.72% | $347.03M | 1.02% |
| FTSD | -32.02% | $231.81M | 0.25% |
| XONE | -27.68% | $625.28M | 0.03% |
| FXY | -27.45% | $816.38M | 0.4% |
| SPTS | -25.81% | $5.80B | 0.03% |
| SCHO | -25.32% | $11.03B | 0.03% |
| VGSH | -25.15% | $22.80B | 0.03% |
| UTWO | -23.30% | $379.52M | 0.15% |
| IBTI | -20.62% | $1.06B | 0.07% |
| IBTH | -20.20% | $1.62B | 0.07% |
| STPZ | -18.74% | $450.47M | 0.2% |
| BWX | -18.73% | $1.53B | 0.35% |
| IBTJ | -18.23% | $688.19M | 0.07% |
| IBTG | -17.87% | $1.92B | 0.07% |
| XHLF | -17.45% | $1.73B | 0.03% |
| IEI | -17.38% | $15.48B | 0.15% |
| IBTK | -16.90% | $448.89M | 0.07% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GOVI | 0.02% | $929.28M | 0.15% |
| IAU | 0.03% | $46.70B | 0.25% |
| GLD | 0.06% | $100.19B | 0.4% |
| IAGG | 0.07% | $10.44B | 0.07% |
| OUNZ | -0.08% | $1.73B | 0.25% |
| MLN | 0.09% | $541.74M | 0.24% |
| CORN | 0.12% | $44.67M | 0.2% |
| AAAU | -0.12% | $1.54B | 0.18% |
| TBIL | -0.16% | $5.81B | 0.15% |
| GLDM | -0.21% | $15.74B | 0.1% |
| BOXX | -0.24% | $6.80B | 0.19% |
| BILZ | 0.28% | $821.74M | 0.14% |
| BAR | -0.31% | $1.11B | 0.1749% |
| FXC | -0.37% | $93.16M | 0.4% |
| TFLO | -0.38% | $6.82B | 0.15% |
| SGOL | -0.42% | $5.17B | 0.17% |
| BIL | -0.48% | $42.24B | 0.1356% |
| BNDW | -0.57% | $1.29B | 0.05% |
| IBTF | -0.60% | $1.99B | 0.07% |
| LMBS | 0.60% | $5.11B | 0.64% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TU | 0.01% | $24.75B | +7.77% | 7.12% |
| DOGZ | -0.12% | $121.58M | -48.38% | 0.00% |
| GFI | 0.17% | $21.56B | +57.55% | 2.31% |
| NGG | -0.18% | $69.22B | +19.52% | 4.29% |
| TEF | -0.32% | $30.08B | +25.41% | 6.16% |
| K | 0.33% | $27.76B | +41.17% | 2.85% |
| AEP | -0.39% | $55.16B | +17.93% | 3.54% |
| LTM | -0.42% | $12.63B | -95.46% | 2.42% |
| AIFU | 0.50% | $6.79B | +102.19% | 0.00% |
| STG | -0.54% | $30.78M | -22.51% | 0.00% |
| VSA | 0.60% | $8.67M | -19.04% | 0.00% |
| SYPR | 0.61% | $48.49M | +14.05% | 0.00% |
| MSIF | 0.62% | $769.47M | +36.17% | 7.61% |
| CCRN | 0.88% | $429.13M | -3.89% | 0.00% |
| CASI | -0.91% | $20.61M | -74.66% | 0.00% |
| PPC | -0.96% | $10.84B | +33.46% | 0.00% |
| PHYS.U | -1.11% | - | - | 0.00% |
| CNC | -1.16% | $16.81B | -49.40% | 0.00% |
| BULL | -1.26% | $6.47B | +25.76% | 0.00% |
| MOH | 1.33% | $12.95B | -19.36% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -12.91% | $24.23B | +35.36% | 1.09% |
| ED | -10.63% | $36.00B | +12.64% | 3.34% |
| DFDV | -10.16% | $300.56M | +2,130.16% | 0.00% |
| ASPS | -9.49% | $108.30M | -4.13% | 0.00% |
| LITB | -8.00% | $21.24M | -78.57% | 0.00% |
| FTS | -7.45% | $23.62B | +20.13% | 3.70% |
| CYCN | -7.38% | $10.59M | +46.35% | 0.00% |
| UUU | -6.98% | $7.17M | +101.30% | 0.00% |
| CME | -6.49% | $99.39B | +40.68% | 3.86% |
| AWK | -5.85% | $27.36B | +9.65% | 2.21% |
| COR | -5.83% | $56.44B | +30.86% | 0.74% |
| KR | -5.56% | $46.43B | +38.38% | 1.85% |
| DG | -4.93% | $25.41B | -7.95% | 2.05% |
| VSTA | -4.40% | $344.07M | +39.29% | 0.00% |
| VRCA | -4.15% | $59.96M | -91.36% | 0.00% |
| BTI | -3.31% | $103.67B | +50.78% | 6.33% |
| AMT | -2.65% | $104.32B | +14.40% | 3.00% |
| SRRK | -2.63% | $3.38B | +357.53% | 0.00% |
| DUK | -2.58% | $90.99B | +17.25% | 3.56% |
| MO | -2.57% | $99.67B | +28.77% | 6.90% |
SeekingAlpha
Publicly listed US equity REITs ended June at a median 19.1% discount to their consensus NAV per share estimates, according to S&P Global Market Intelligence data.
Yahoo
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, announces the acceptance for publication of a research article entitled "Liposomal-Cannabidiol Injection: Preliminary Insights into Pharmacokinetics and Safety Characteristics in Göttingen Minipigs and Rabbits" in the esteemed journal Precision Nanomedicine.
Yahoo
Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it will report financial results for the second quarter of 2025 on Tuesday, August 5, 2025, after the market closes.
Yahoo
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577) has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las V
Yahoo
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries proudly announces the third party publication of a peer-reviewed narrative review in Cureus journal titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577). The article discusses the therapeutic potential of long-acting synthetic cannabidiol (CBD) in addressing ch
SeekingAlpha
Summit Hotel Properties offers an attractive 7% dividend yield, strong earnings coverage, and a healthy balance sheet. Read an analysis of INN stock here.
